Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Philly Pelvic Mesh Trial Ends In Largest Verdict Against Ethicon

Executive Summary

A Philadelphia jury awarded $57m to a woman who says she was injured by Ethicon pelvic mesh products in the fifth judgement against the company in the city’s Court of Common Pleas.

You may also be interested in...



Pennsylvania Jury Slams Ethicon With $41M Verdict In Mesh Case

Johnson & Johnson subsidiary Ethicon has been ordered to pay $41m to a plaintiff who says she was injured by the company’s pelvic mesh products.

J&J Wins Mesh Case, But Slammed With $247m Penalty On Hips

The company’s Ethicon business unit was cleared on allegations a pelvic mesh product had injured a Texas woman, while a jury in a separate trial issued a $247m award to patients claiming injury from the DePuy Orthopaedics Pinnacle hip.

Pelvic Mesh Cases Continue As Endo Moves To Settle

Endo International announced plans this week to pay $775m to settle 22,000 US claims. Meanwhile, J&J is launching its sixth mesh lawsuit in Philadelphia and questioning jurisdiction.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT121486

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel